Winfried Krueger
Lentigen Technology (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, CRISPR and Genetic Engineering, Pluripotent Stem Cells Research, RNA Interference and Gene Delivery, Genomics and Chromatin Dynamics
Most-Cited Works
- → Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial(2020)443 cited
- → Expression Profile of Osteoblast Lineage at Defined Stages of Differentiation(2005)171 cited
- → Activation of Human Monocytes by Live Borrelia burgdorferi Generates TLR2-Dependent and -Independent Responses Which Include Induction of IFN-β(2009)160 cited
- → Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model(2019)154 cited
- → Cloning and characterization of MVP17: A developmentally regulated myelin protein in oligodendrocytes(1995)140 cited
- → Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models(2021)138 cited
- → Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma(2020)95 cited
- → A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy(2019)84 cited
- → ES Cell Cycle Progression and Differentiation Require the Action of the Histone Methyltransferase Dot1L(2009)81 cited
- → Epigenetic regulatory mechanisms during preimplantation development(2009)79 cited